We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
The World Health Organization (WHO) has issued a medical alert for 2 substandard (contaminated) products identified in Uzbekistan. Substandard medical products are products that fail to meet either their quality standards or specifications.
The 2 products, AMBRONOL syrup and DOK-1 Max syrup,were identified by the regulatory authorities in Uzbekistan as containing unacceptable amounts of ethylene glycol and/or diethylene glycol which is toxic to humans when consumed and can prove fatal.
The WHO have advised there is a possibility these products may have been distributed to other countries or regions through informal markets.
Substandard and falsified (counterfeit) medical products are a growing problem that occurs throughout the world. A wide range of substandard and counterfeit medicines are available, including pain medications, antimalarials, antibiotics, blood pressure medicine and vaccines.
If during travel a traveller requires medication for a new illness or condition they should be advised:
Travellers who take regular or intermittent medication should be encouraged to obtain these in the UK prior to travel, especially if there is any cause for concern about the legitimacy or quality of medications or medical products at their destination.
In the event that further medicines need to be obtained abroad (for example, if a trip is extended, medicines are lost or stolen or the planned itinerary is changed) then travellers, in addition to the measures above, should also be advised:
See the TRAVAX Counterfeit Medicines and Travelling with Medicines pages for further information.